top of page

Colorado Lawmakers Send Psychedelics Bill To Governor To Allow Pardons And Implement Data-Tracking

  • Writer: Bob Marley
    Bob Marley
  • May 6, 2025
  • 3 min read

Colorado’s House of Representatives has approved a Senate-passed bill to empower the governor to grant pardons to people who’ve been convicted of psychedelics-related offenses and also revise implementation rules and data-tracking provisions for the state’s 2022 voter-approved psychedelics legalization law.

House members voted 43–22 in favor of SB25-297 during third reading on Tuesday, following Senate passage of the proposal on a 23–12 vote last week. With approval by both chambers, the measure now proceeds to the desk of Gov. Jared Polis (D).

If enacted, the bill would authorize Polis or future governors to grant clemency to people with convictions for low-level possession of substances such as psilocybin, ibogaine and DMT that have since been legalized for adults.

It would also require the Colorado Department of Public Health and Environment (CDPHE), Department of Revenue (DOR) and Department of Regulatory Agencies (DORA) to “collect information and data related to the use of natural medicine and natural medicine products.”

That would include data on law enforcement activities, adverse health events, consumer protection claims and behavioral impacts related to psychedelics.


“What this bill does is it sets up a mechanism to collect health information, which should give us the data to see whether or not natural medicine, as it’s rolled out, has adverse health effects or beneficial health impacts,” Sen. Matt Ball (D), SB25-297’s Senate sponsor, said during discussion on the measure last week.

House sponsor Rep. Lisa Feret (D), meanwhile, noted that as the measure is currently written, the data-tracking program “will be funded by grant dollars, so we will not be taking any more money from this.”

Prior to passage by the Senate, a committee amendment removed a government appropriation to pay for data collection and tracking, replacing a reference to “ongoing appropriations” with “appropriations or gifts, grants, or donations.” Ball said at the time that lawmakers have a letter of intent from the Psychedelic Science Funders Collaborative—a nonprofit that supports advancing psychedelic therapy—to fund the program for the entirety of its five-year duration.

The bill would earmark $208,240 in those funds for the governor’s office of information technology. “To implement this act, the office may use this appropriation to provide information technology services for the department of public health and environment,” the text version says.

The legislation would further amend rules around licensing and ownership of psychedelic healing centers. For example, it removes a requirement for fingerprint background checks for owners and employees of licensed facilities, making it so they would only be subject to a name-based criminal background check.

It additionally “requires the state licensing authority to adopt rules related to product labels for regulated natural medicine and regulated natural medicine products and permits the state licensing authority to adopt rules regarding the types of regulated natural medicine products that can be manufactured.”

The proposal overall has support from an array of advocates, including psychedelic medicine proponents as well as groups more skeptical of legalization. Public commenters at a hearing last month seemed to agree that the bill’s data collection provisions would help observers both inside and outside Colorado better understand the outcomes around regulated psychedelics.

Meanwhile in Colorado, last month the governor signed into law a bill that would allow a form of psilocybin to be prescribed as a medication if the federal government authorizes its use.

While Colorado already legalized psilocybin and several other psychedelics for adults 21 and older through the voter-approved ballot initiative, the newly enacted reform will make it so drugs containing an isolated crystalized version synthesized from psilocybin can become available under physician prescription.

As of January, meanwhile, Colorado regulars have been authorized to approve licenses for psilocybin service centers where adults can access the psychedelic in controlled settings.

The governor signed a bill to create the regulatory framework for legal psychedelics in 2023.

But lawmakers evidently are interested in setting the state up to allow for a more conventional system of distribution for certain psychedelics. In 2022, Polis also signed a bill to align state statute to legalize MDMA prescriptions if and when the federal government ultimately permits such use.

Whether FDA moves forward with any such approvals in uncertain, and the agency faced criticism last year after rejecting an application to allow MDMA-assisted therapy for people with PTSD.

Meanwhile in Colorado, a bill that would have limited THC in marijuana and outlawed a variety of psilocybin products will no longer move forward this session following the lead sponsor’s move to withdraw the bill.

Pennsylvania Governor Will Put Marijuana Legalization In His Budget, But Top GOP Senator Remains Skeptical

Comments


Global SEO Keywords

marihuana, cannabis, cáñamo, CBD, aceite de CBD, bálsamo de CBD, marijuana, hemp, weed, CBD oil, CBD balm, canapa, erba, olio di CBD, balsamo CBD, chanvre, herbe, huile de CBD, baume CBD, Marihuana, Cannabis, Hanf, Gras, CBD Öl, CBD Balsam, maconha, cânhamo, erva, óleo de CBD, bálsamo CBD, hennep, wiet, CBD olie, CBD balsem, hampa, gräs, CBD olja, CBD balsam, hamp, græs, gress, CBD olje, hamppu, ruoho, CBD öljy, CBD balsami, konopie, konopie indyjskie, olej CBD, balsam CBD, konopí, CBD olej, CBD balzám, konope, CBD balzam, marihuána, kannabisz, kender, fű, CBD olaj, CBD balzsam, canabis, cânepă, iarbă, ulei CBD, марихуана, канабис, коноп, CBD масло, CBD балсам, μαριχουάνα, κάνναβη, χασίς, λάδι CBD, βάλσαμο CBD, kanabis, konoplja, trava, CBD ulje, CBD olje, kanapės, kanapės indinės, CBD aliejus, CBD balzamas, marihuāna, kaņepes, CBD eļļa, CBD balzams, marihuaana, kanep, CBD õli, CBD palsam, kannabis, qanneb, żejt CBD, balsam CBD, marijúna, hampur, CBD olía, CBD smyrsl

Disclaimer

Jacob Hooy CBD Lip Balm is free from parabens and artificial colorants and contains no toxins or heavy metals, supporting natural body care. Our products are not intended to diagnose, treat, cure, or prevent any disease, medical condition, or symptom. The information provided on this website is for informational purposes only and must not be considered medical advice, nor a substitute for professional diagnosis, treatment, or guidance provided by qualified physicians, healthcare professionals, or pharmaceutical specialists. Nothing on this website should be interpreted as a recommendation, prescription, or therapeutic claim.

Difresh Spain is an online retail store registered under IAE Group 652.3, specializing in the retail trade of perfumery, cosmetic products, and personal hygiene and care items. NIF: Y3526859-F. E-mail: info@cbdvending.eu - WhatsApp: +34662918154 - Factory adress: Calle Albardín 13, Nave B07, 50720, La cartuja baja, Zaragoza, España. All prices include VAT and free shipping across all European Union countries.

© 2026 - www.cbdvending.euPrivacy Policy

bottom of page